Predicting survival in locally advanced gastric cancer using prognostic factors – neoadjuvant rectal score and downstaging depth score

Authors

Keywords:

locally advanced gastric cancer, neoadjuvant rectal score, downstaging depth score, gastric cancer, neoadjuvant therapy

Abstract

Background: Clinical prediction models are needed to accurately predict the prognosis of patients with gastric cancer who have received neoadjuvant therapy and to determine the best treatment strategies. The aim of this study is to determine the role of two prognostic factors, the neoadjuvant rectal (NAR) score and the downstaging depth score (DDS), in predicting survival in patients with gastric cancer who received neoadjuvant therapy and underwent curative gastrectomy.

Methods: We reviewed the medical records of 129 patients who had been diagnosed with primary gastric cancer and underwent radical gastrectomy after receiving neoadjuvant therapy. We calculated the NAR score and DDS values for each patient and conducted a survival analysis to assess the accuracy of these prognostic factors in predicting overall survival.

Results: The median overall survival time of the patients was found to be 29 months. Patients with low NAR scores and high DDS had significantly longer overall survival. Univariate analyses based on clinical and laboratory characteristics showed that gender, surgery type, resection type, neural invasion, grade, adjuvant radiotherapy, lymphocyte level, carcinoembryonic antigen (CEA) level, NAR score, and DDS were associated with survival. Moreover, multivariate analyses showed that lymphocyte level, DDS, and NAR score were independent prognostic factors.

Conclusions: In summary, our research indicates that NAR score and DDS may serve as useful prognostic markers for predicting overall survival in patients with locally advanced gastric cancer who receive neoadjuvant chemotherapy followed by curative surgery. Patients with high DDS and low NAR scores were found to have better prognoses.

Author Biographies

S Tamam, Ankara University School of Medicine

Division of Surgical Oncology, Department of Surgery, Ankara University Cebeci Hospital, Ankara University School of Medicine, Turkey

S Culcu, Ankara University School of Medicine

Division of Surgical Oncology, Department of Surgery, Ankara University Cebeci Hospital, Ankara University School of Medicine, Turkey

K Erözkan, Ankara University School of Medicine

Division of Surgical Oncology, Department of Surgery, Ankara University Cebeci Hospital, Ankara University School of Medicine, Turkey

MS Benk, Ankara University School of Medicine

Division of Surgical Oncology, Department of Surgery, Ankara University Cebeci Hospital, Ankara University School of Medicine, Turkey

C Azılı, Ankara University School of Medicine

Division of Surgical Oncology, Department of Surgery, Ankara University Cebeci Hospital, Ankara University School of Medicine, Turkey

E Altınsoy, Ankara University School of Medicine

Division of Surgical Oncology, Department of Surgery, Ankara University Cebeci Hospital, Ankara University School of Medicine, Turkey

Ş Ersöz, Ankara University School of Medicine

Department of Surgery, Ankara University Cebeci Hospital, Ankara University School of Medicine, Turkey

AE Unal, Ankara University School of Medicine

Division of Surgical Oncology, Department of Surgery, Ankara University Cebeci Hospital, Ankara University School of Medicine, Turkey

Downloads

Published

2024-03-28

Issue

Section

Upper Gastrointestinal Surgery